Throughout the last three months, 4 analysts have evaluated Adient (NYSE:ADNT), offering a diverse set of opinions from bullish to bearish.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 1 | 1 | 1 | 1 | 0 |
Last 30D | 0 | 0 | 0 | 1 | 0 |
1M Ago | 0 | 0 | 0 | 0 | 0 |
2M Ago | 1 | 1 | 0 | 0 | 0 |
3M Ago | 0 | 0 | 1 | 0 | 0 |
In the assessment of 12-month price targets, analysts unveil insights for Adient, presenting an average target of $25.0, a high estimate of $30.00, and a low estimate of $19.00. A decline of 11.75% from the prior average price target is evident in the current average.
Investigating Analyst Ratings: An Elaborate Study
The analysis of recent analyst actions sheds light on the perception of Adient by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
---|---|---|---|---|---|
Adam Jonas | Morgan Stanley | Lowers | Underweight | $19.00 | $21.00 |
John Murphy | B of A Securities | Lowers | Buy | $30.00 | $35.00 |
Colin Langan | Wells Fargo | Lowers | Overweight | $27.00 | $29.00 |
Edison Yu | Deutsche Bank | Announces | Hold | $24.00 | - |
Key Insights: Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Adient. This offers insight into analysts' perspectives on the current state of the company. Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Adient compared to the broader market. Price Targets: Analysts predict movements in price targets, offering estimates for Adient's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.
Capture valuable insights into Adient's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
Stay up to date on Adient analyst ratings.
If you are interested in following small-capstock newsand performance you can start by tracking it here.
About Adient
Adient began trading Oct. 31, 2016, when Johnson Controls spun off its automotive experience segment into this new company. Adient is the leading seating supplier to the industry with about one third of theglobal market Its share in China is now nearly 20%, down from about 45%, following the sale of its main joint venture there at the end of fiscal 2021. Unconsolidated seating revenue from joint ventures after factoring in the sale was about $3.8 billion in fiscal 2023 and consolidated China revenue was $1.4 billion. The company is headquartered in Ireland but has corporate offices in the Detroit area. Fiscal 2023 (Sept. 30 year-end) consolidated revenue, which excludes joint venture sales, was $15.4 billion and fiscal 2024 is forecast to about $14.6 billion.
Adient: A Financial Overview
Market Capitalization Analysis: Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.
Revenue Challenges: Adient's revenue growth over 3 months faced difficulties. As of 30 September, 2024, the company experienced a decline of approximately -4.14%. This indicates a decrease in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Consumer Discretionary sector.
Net Margin: Adient's net margin falls below industry averages, indicating challenges in achieving strong profitability. With a net margin of 2.22%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Adient's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 3.89% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): Adient's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of 0.86%, the company may encounter challenges in delivering satisfactory returns from its assets.
Debt Management: Adient's debt-to-equity ratio surpasses industry norms, standing at 1.13. This suggests the company carries a substantial amount of debt, posing potential financial challenges.
How Are Analyst Ratings Determined?
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. Click here to stay ahead of the market.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Latest Ratings for ADNT
Date | Firm | Action | From | To |
---|---|---|---|---|
Feb 2022 | Wells Fargo | Maintains | Overweight | |
Dec 2021 | Barclays | Downgrades | Overweight | Equal-Weight |
Nov 2021 | Barclays | Maintains | Overweight |
View More Analyst Ratings for ADNT
View the Latest Analyst Ratings
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.